CIMA LABS INC. is a drug delivery technology company. We develop and manufacture prescription and over-the-counter medication based on proprietary, orally disintegrating technologies (also referred to as fast dissolve, fast melt and fast disintegrating). OraSolv® and DuraSolv® orally disintegrating tablets (ODTs) disperse quickly in the mouth without chewing or the need for water - making it easier for patients to take medication. OraVescent® is an oral transmucosal tablet that can be administered buccally or sublingually.

Our ODTs provide a wide range of benefits to products, including differentiation, life cycle management, overcoming formulation challenges, convenience and ease of administration. We work with partner’s products and also develop proprietary products.

Our expertise encompasses:

• Taste-masking
• Rapid development timelines
• Commercial manufacturing

CIMA is a subsidiary of Cephalon, Inc. (www.cephalon.com).